Q32 Bio Inc. /
Homology Medicines, Inc.
Q32 and Homology Medicines to combine in reverse merger
What happened
Q32 Bio Inc. and Homology Medicines, Inc. are parties to a merger described in the filing as a reverse merger. The combined company will be named Q32 Bio Inc.
The filing describes Q32’s clinical development pipeline, but does not provide a qualifying sentence stating the merger stage or its terms.
The source
Everything on this page comes from the source below.
Q32 and Homology Medicines to combine in reverse merger
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly